17 transactions in one company, from November 18, 2025 to December 1, 2025.
Where this insider traded.
| Company | Ticker | Trades | Bought | Sold |
|---|---|---|---|---|
| Inmune Bio, Inc. | INMB | 17 | — | — |
17 in total, newest filings first.
| Company | Ticker | Insider | Date | Code | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|---|
| Inmune Bio, Inc. | INMB | James Kelly GanjeiDirDERIV | Dec 1 | AAward | 150,000 | $0.00 | —? | 150,000derivatives |
| Inmune Bio, Inc. | INMB | James Kelly GanjeiDirDERIV | Nov 18 | AAward | 12,500 | — | — | 12,500derivatives |
| Inmune Bio, Inc. | INMB | James Kelly GanjeiDirDERIV | Nov 18 | DReturned to issuer | 12,500 | — | — | 0derivatives |
| Inmune Bio, Inc. | INMB | James Kelly GanjeiDirDERIV | Nov 18 | AAward | 32,500 | — | — | 32,500derivatives |
| Inmune Bio, Inc. | INMB | James Kelly GanjeiDirDERIV | Nov 18 | DReturned to issuer | 32,500 | — | — | 0derivatives |
| Inmune Bio, Inc. | INMB | James Kelly GanjeiDirDERIV | Nov 18 | AAward | 35,000 | — | — | 35,000derivatives |
| Inmune Bio, Inc. | INMB | James Kelly GanjeiDirDERIV | Nov 18 | DReturned to issuer | 35,000 | — | — | 0derivatives |
| Inmune Bio, Inc. | INMB | James Kelly GanjeiDirDERIV | Nov 18 | AAward | 35,000 | — | — | 35,000derivatives |
| Inmune Bio, Inc. | INMB | James Kelly GanjeiDirDERIV | Nov 18 | DReturned to issuer | 35,000 | — | — | 0derivatives |
| Inmune Bio, Inc. | INMB | James Kelly GanjeiDirDERIV | Nov 18 | AAward | 19,025 | — | — | 19,025derivatives |
| Inmune Bio, Inc. | INMB | James Kelly GanjeiDirDERIV | Nov 18 | DReturned to issuer | 19,025 | — | — | 0derivatives |
| Inmune Bio, Inc. | INMB | James Kelly GanjeiDirDERIV | Nov 18 | AAward | 15,975 | — | — | 15,975derivatives |
| Inmune Bio, Inc. | INMB | James Kelly GanjeiDirDERIV | Nov 18 | DReturned to issuer | 15,975 | — | — | 0derivatives |
| Inmune Bio, Inc. | INMB | James Kelly GanjeiDirDERIV | Nov 18 | AAward | 108,000 | — | — | 108,000derivatives |
| Inmune Bio, Inc. | INMB | James Kelly GanjeiDirDERIV | Nov 18 | DReturned to issuer | 108,000 | — | — | 0derivatives |
| Inmune Bio, Inc. | INMB | James Kelly GanjeiDirDERIV | Nov 18 | AAward | 108,000 | — | — | 108,000derivatives |
| Inmune Bio, Inc. | INMB | James Kelly GanjeiDirDERIV | Nov 18 | DReturned to issuer | 108,000 | — | — | 0derivatives |